Infertility, Female
Conditions
Brief summary
The purpose of this research study is to evaluate Overture's automated Intracytoplasmic Sperm Injection (ICSIA) System. ICSIA is an investigational medical device that automates injection of sperm into eggs. This study will evaluate survival and fertilization rates of oocytes handled via ICSIA and compare to survival and fertilization rates of oocytes which are manually injected with sperm.
Detailed description
Today Intracytoplasmic Sperm Injection (ICSI) is performed manually; a highly skilled technician manually injects a single sperm cell into an oocyte using a set of microinjectors. Success of ICSI is contingent on operator skills and has a direct impact on the number of fertilized oocytes available and cumulative pregnancy rates. Automation of the ICSI technique may help improve consistency and efficiency of the process, as well as improve reproducibility across operators. Overture has developed the ICSI system to automate these critical processes, named ICSIA. ICSIA is composed of the same devices and consumables used for manual ICSI, but these devices have been integrated using a software interface with artificial intelligence to identify oocytes and allow for proper puncture of the oocyte and injection of the sperm without human intervention. The information from this study will be used by the study Sponsor, Overture Life, Inc, to help future development of the System and for submission of data to the United States Food and Drug Administration (FDA). During the study, patients will undergo a conventional IVF cycle, or donor IVF cycle. After the oocyte retrieval or thawing of donor oocytes, the oocytes will be placed into equal groups: test and control. Test group oocytes will undergo ICSI via ICSIA (the investigational device), and control group oocytes will undergo manual ICSI as is routinely performed. The oocytes will be immediately evaluated for survival and fertilization rates and remain separate for the duration of the study. ICSIA has been extensively tested in hamster and mice oocytes, and fertilization/survival rates after ICSIA have been between 89%-96%. After ICSI, conventional IVF processes will be followed and fertilized oocytes cultured up to blastocyst stage. Blastocysts will be biopsied for preimplantation genetic testing for aneuploidy (PGT-A) which assesses the embryo's chromosomes. All biopsied blastocysts will be frozen, and frozen embryo transfers (FET) scheduled after genetic results have been received. Embryo freezing and thaw will be performed manually. Selection of the embryo for transfer (whether test or control) will be at random.
Interventions
DEVICEInvestigational device named ICSIA
Oocytes will undergo intracytoplasmic sperm injection using the ICSIA (the investigational) device.
DEVICEManual ICSI
Oocytes will undergo intracytoplasmic sperm injection using the ICSI manual protocol
Sponsors
New Hope Fertility Center
Overture Life
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Intervention model description
After the oocyte retrieval or thawing of donor oocytes, oocytes will be randomly assigned into equal groups: test and control. Test group oocytes will undergo ICSI via ICSIA (the investigational device), and control group oocytes will undergo manual ICSI as is routinely performed.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Infertile women undergoing IVF treatment with ICSI
Exclusion criteria
* Severe male factor infertility
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival rates | Between 0 hours and 2 hours post-ICSI | It refers to the integrity of the oocytes after sperm injection out of the total number of oocytes injected. |
| Fertilization rates | Between 16 hours and 20 hours post-ICSI | It refers to the number of oocytes that show to be correctly fertilized showing two pronuclei and a second polar body out of the total number of oocytes injected. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Blastocyst rates | Between 120 hours and 168 hours post-ICSI | Refers to the number of fertilized embryos that develop into a good quality blastocyst after 5-7 days of in vitro culture |
| Euploidy rates | 1 month after biopsy | Refers to the number of blastocysts that are biopsied that are diagnosed as euploid |
| Clinical pregnancy rates | 6 weeks after embryo transfer | Refers to the number of patients that are replaced with an embryo and result pregnant with fetal heartbeat out of the total patients that are transferred. |
Countries
United States
Outcome results
None listed